Your search returned 37 results. Subscribe to this search

Not what you expected? Check for suggestions
|
1. 106P Experience of 22 patients with ROS mutated lung adenocarcinoma treated with crizotinib at a tertiary care center in India

by Talreja V | Pande N.

In Annals of oncology
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

2. 1098P Incidence and impact of DPD mutation on neoadjuvant chemotherapy in head and neck cancers

by Turkar SW | Chougule A | Patil V | Noronha V | Joshi A | Pande N | Chandrashekharan A | Prabhash K.

In Annals of Oncology
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

3. 165P Analysis of our experience of ROS-1 patients in advanced NSCLC

by Pande N [Corresponding Author] | Joshi A | Noronha V | Patil V | Mahajan A | Prabhash K.

In Journal of Thoracic Oncology
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

4. 337O Quality of life without toxicity or symptoms analysis of a randomized controlled clinical trial comparing efficacy of Cabazitaxel versus docetaxel in recurrent Head and Neck Cancer

by Talreja VT | Patil V | Joshi A | Noronha V | Chandrasekharan A | Dhumal S | Pande N | Turkar S | Shrirangwar S | Mahajan A | Juvrekar S | Bhattacharjee A | Prabhash K.

In Annals of Oncology
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

5. 342P QOL analysis of a phase II randomized controlled clinical trial comparing efficacy of cabazitaxel versus docetaxel as second line or above therapy in recurrent head and neck cancer

by Chanana R | Noronha V | Joshi A | Patil V | Dhumal S | Bhattacharya A | Chandrasekharan A | Pande N | Talreja VT | Turkar S | Shrirangwar S | Prabhash K.

In Annals of Oncology
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

6. Assessing the Potential Role of Scaffold-Mediated Local Chemotherapy in Oral Cancer

by Gupta AA [Corresponding Author] | Pande N [Corresponding Author] | Kheur S [Corresponding Author] | Raj AT [Corresponding Author].

In Oral Oncology.
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

7. A cross-sectional audit of distress in patients undergoing adjuvant therapy or follow-up in central nervous system malignancies

by Patil VM [Corresponding Author] | Malhotra M | Tonse R | Deodhar J | Chandrasekharan A | Pande N | Bhattacharjee A | Jalali A.

In Neuro-Oncology Practice
Material type: article Article; Format: print Publisher: 2019Availability: Items available for loan: Tata Memorial Hospital (1).

8. Distress Management in Patients With Head and Neck Cancer Before Start of Palliative Chemotherapy: A Practical Approach

by Patil V | Noronha V | Joshi A | Deodhar J | Goswami S | Chakraborty S | Ramaswamy A | Dhumal S | Chandrakanth MV | Karpe A | Pande N | Talreja V | Chandrasekharan A | Turkar S | Prabhash K [Corresponding author].

In Journal of Global Oncology
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

9. Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?

by Joshi A | Joshi A | Patil V | Noronha V | Chougule A | Bhattacharjee A | Kumar R | Goud S | More S | Ramaswamy A | Karpe A | Pande N | Chandrasekharan A | Goel A | Talreja V | Mahajan A | Janu A | Purandare N | Prabhash K [Corresponding author].

In Lung India
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

10. Efficacy of Gefitinib in Epidermal Growth Factor Receptor-Activating Mutation-Positive Nonsmall Cell Lung Cancer: Does Exon 19 Deletion Differ from Exon 21 Mutation?

by Joshi A | Patil V | Noronha V | Chougule A | Bhattacharjee A | Kumar R | Goud S | More S | Ramaswamy A | Karpe A | Pande N | Chandrasekharan A | Goel A | Talreja V | Mahajan A | Janu A | Purandare N | Prabhash K [Corresponding Author].

In Lung India
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

11. Efficacy of Second-Line Pemetrexed-Carboplatin in EGFR-Activating Mutation-Positive NSCLC: Does Exon 19 Deletion Differ from Exon 21 Mutation?

by Joshi A | Noronha V | Patil VM | Chougule A | Bhattacharjee A | Kumar R | Goud S | More S | Ramaswamy A | Karpe A | Pande N | Chandrasekharan A | Goel A | Talreja V | Mahajan A | Janu A | Purandare N | Prabhash K.

In Chemotherapy Research and Practice
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

12. Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed–carboplatin chemotherapy

by Noronha V | Patil V | Joshi A | Chougule A | Bhattacharjee A | Kumar R | More S | Goud S | Karpe A | Ramaswamy A | Pande N | Chandrasekharan A | Goel A | Talreja V | Mahajan A | Janu A | Purandare N | Prabhash K.

In Ecancermedicalscience
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

13. Incidence and impact of dihydropyrimidine dehydrogenase gene mutation on neoadjuvant chemotherapy in head and neck cancers

by Chougule A | Patil VM | Noronha V | Joshi A | Turkkar S | Chandrasekharan A | Pande N | Bagayatkar P | Prabhash K [Corresponding author].

In Oral Oncology
Material type: article Article; Format: print Publisher: Amsterdam : Elsevier, 2017Availability: Items available for loan: Tata Memorial Hospital (1).

14. Influence of Hypothyroidism After Chemoradiation on Outcomes in Head and Neck Cancer.

by Patil VM | Noronha V | Joshi A | Bhattacharjee A | Goel A | Talreja V | Chandrasekharan A | Pande N | Mandal T | Ramaswamy A | Prabhash K [Corresponding author].

In Clinical Oncology
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

15. Nontrial, Real-World Outcomes in Unresectable Locally Advanced Pancreatic Cancer: Chemotherapy and Chemoradiation is the Standard while Surgery is Uncommon.

by Ramaswamy A | Jandyal S | Ostwal V [Corresponding Author] | Engineer R | Lewis S | Bose S | Pande N | Shrikhande SV.

In Indian Journal of Cancer
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

16. Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial.

by Noronha V | Joshi A | Patil VM | Agarwal J | Ghosh-Laskar S | Budrukkar A | Murthy V | Gupta T | D'Cruz AK | Banavali S | Pai PS | Chaturvedi P | Chaukar D | Pande N | Chandrasekharan A | Talreja V | Vallathol DH | Mathrudev V | Manjrekar A | Maske K | Bhelekar AS | Nawale K | Kannan S | Gota V | Bhattacharjee A | Kane S | Juvekar SL | Prabhash K [Corresponding Author].

In Journal of Clinical Oncology
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

17. P3.02b-007 Differential Efficacy of Gefitinib in Exon 19 or Exon 21 Mutated Adenocarcinoma Lung

by Goel A | Joshi A | Patil V | Noronha V | Chougule A | Mahajan A | Janu A | Kaushal R | Goud S | More S | Karpe A | Ramaswamy A | Pande N | Chandrasekharan A | Talreja V | Chanana R | Prabhash K.

In Journal of Thoracic Oncology
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

18. P3.02b-055 Impact of pemetrexed chemotherapy in exon 19 or exon 21 mutated nsclc

by Talreja V | Noronha V | Patil V | Joshi A | Chougule A | Mahajan A | Janu A | Goud S | More S | Karpe A | Ramaswamy A | Pande N | Chandrasekharan A | Goel A | Prabhash K.

In Journal of Thoracic Oncology
Material type: article Article; Format: print Publisher: New York, NY : Elsevier 2017Online access: PDF Availability: Items available for loan: Tata Memorial Hospital (1).

19. P3.02b-058 Second-Line Therapy in EGFR Activating Mutation Positive Advanced NSCLC: Analysis from a Randomized Phase III First-Line Trial

by Ramaswamy A | Patil V | Joshi A | Noronha V | Choughule A | Mahajan A | Goud S | More S | Karpe A | Pande N | Chandrasekharan A | Goel A | Talreja V | Prabhash K.

In Journal of Thoracic Oncology
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

20. P3.02b-090 Pemetrexed versus gefitinib in egfr mutation positive lung cancer: results of a phase 3 study from India

by Kumar Prabhash | Patil V | Joshi A | Noronha V | Chougule A | Mahajan A | Janu A | Goud S | More S | Kaushal R | Karpe A | Ramaswamy A | Pande N | Talreja V.

In Journal of Thoracic Oncology
Material type: article Article; Format: print Publisher: New York, NY : Elsevier 2017Online access: PDF Availability: Items available for loan: Tata Memorial Hospital (1).

Powered by Koha